FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213901742> ?p ?o ?g. }

• W3213901742 endingPage "S72" @default.
• W3213901742 startingPage "S71" @default.
• W3213901742 abstract "Background Relapsed/refractory multiple myeloma (RRMM) is characterized by a high inter- and intratumor heterogeneity and a complex interplay of myeloma cells with the bone marrow microenvironment (BME). Accordingly, there is an urgent need to dissect subclone structure, transcriptional heterogeneity and cellular interactions to unravel the molecular mechanisms underlying drug resistance in RRMM. Methods Single cell RNA sequencing (scRNA-seq) of ~210,000 cells from bone marrow aspirates sorted into CD138+ and CD138– fractions was conducted for 20 heavily pretreated RRMM patients. RRMM subclones were called from the scRNA-seq data based on a copy number aberration (CNA) analysis that was confirmed by interphase fluorescence in situ hybridization and whole genome sequencing. From the scRNA-seq data the composition and abundance of immune cell types in the BME was determined. Interactions of myeloma cells with the BME were characterized by an analysis of the correlated expression of ligand-receptor pairs. Selected findings from the scRNA-seq analysis were validated by flow cytometry. Results Subclones with distinct chromosomal aberrations were reliably identified at the single cell level based on CNAs inferred from scRNA-seq data. The analysis revealed a subclonal 1q-gain (+1q) in 10/20 samples, for which a gene expression signature of recurrently upregulated genes was derived. These +1q subclones frequently expanded during treatment. Furthermore, RRMM cells shaped an immune suppressive BME by upregulation of inflammatory cytokines and close interplay with the myeloid compartment. RRMM cells appear to reprogram the BME by upregulation of inflammatory cytokines and ligands of inhibitory receptors expressed on T and NK-cells. Specifically, the immune cell compartment of RRMM patients displayed an accumulation of PD1+ γδ T-cells and myeloid populations compared to healthy donors or early disease. In addition, we observed a depletion of hematopoietic progenitors in patients with high expression of genes associated with inflammatory signaling in the BME. Upon treatment with immunomodulatory drugs, reprogrammed plasmacytoid dendritic cells expanded. Focusing on patients with +1q, we found an enrichment of a rare M2-like tumor associated macrophage population while GZMB+ NK effector cells were depleted in these patients, indicating that +1q has a distinct effect on the BME in RRMM. Conclusions Our study resolves transcriptional features of subclones in RRMM and mechanisms of microenvironmental reprogramming. The insight gained in our study on the evolution of RRMM heterogeneity and its bone marrow milieu will support the development of novel treatment approaches and potentially guide clinical decision making. Relapsed/refractory multiple myeloma (RRMM) is characterized by a high inter- and intratumor heterogeneity and a complex interplay of myeloma cells with the bone marrow microenvironment (BME). Accordingly, there is an urgent need to dissect subclone structure, transcriptional heterogeneity and cellular interactions to unravel the molecular mechanisms underlying drug resistance in RRMM. Single cell RNA sequencing (scRNA-seq) of ~210,000 cells from bone marrow aspirates sorted into CD138+ and CD138– fractions was conducted for 20 heavily pretreated RRMM patients. RRMM subclones were called from the scRNA-seq data based on a copy number aberration (CNA) analysis that was confirmed by interphase fluorescence in situ hybridization and whole genome sequencing. From the scRNA-seq data the composition and abundance of immune cell types in the BME was determined. Interactions of myeloma cells with the BME were characterized by an analysis of the correlated expression of ligand-receptor pairs. Selected findings from the scRNA-seq analysis were validated by flow cytometry. Subclones with distinct chromosomal aberrations were reliably identified at the single cell level based on CNAs inferred from scRNA-seq data. The analysis revealed a subclonal 1q-gain (+1q) in 10/20 samples, for which a gene expression signature of recurrently upregulated genes was derived. These +1q subclones frequently expanded during treatment. Furthermore, RRMM cells shaped an immune suppressive BME by upregulation of inflammatory cytokines and close interplay with the myeloid compartment. RRMM cells appear to reprogram the BME by upregulation of inflammatory cytokines and ligands of inhibitory receptors expressed on T and NK-cells. Specifically, the immune cell compartment of RRMM patients displayed an accumulation of PD1+ γδ T-cells and myeloid populations compared to healthy donors or early disease. In addition, we observed a depletion of hematopoietic progenitors in patients with high expression of genes associated with inflammatory signaling in the BME. Upon treatment with immunomodulatory drugs, reprogrammed plasmacytoid dendritic cells expanded. Focusing on patients with +1q, we found an enrichment of a rare M2-like tumor associated macrophage population while GZMB+ NK effector cells were depleted in these patients, indicating that +1q has a distinct effect on the BME in RRMM. Our study resolves transcriptional features of subclones in RRMM and mechanisms of microenvironmental reprogramming. The insight gained in our study on the evolution of RRMM heterogeneity and its bone marrow milieu will support the development of novel treatment approaches and potentially guide clinical decision making." @default.
• W3213901742 created "2021-11-22" @default.
• W3213901742 creator A5001651530 @default.
• W3213901742 creator A5006013275 @default.
• W3213901742 creator A5007067641 @default.
• W3213901742 creator A5019570679 @default.
• W3213901742 creator A5023929019 @default.
• W3213901742 creator A5028388949 @default.
• W3213901742 creator A5029489836 @default.
• W3213901742 creator A5034285292 @default.
• W3213901742 creator A5038346337 @default.
• W3213901742 creator A5052636654 @default.
• W3213901742 creator A5055916434 @default.
• W3213901742 creator A5061170036 @default.
• W3213901742 creator A5061326208 @default.
• W3213901742 creator A5061648636 @default.
• W3213901742 creator A5063410783 @default.
• W3213901742 creator A5066282715 @default.
• W3213901742 creator A5070221339 @default.
• W3213901742 creator A5081998180 @default.
• W3213901742 creator A5084645599 @default.
• W3213901742 creator A5091002491 @default.
• W3213901742 date "2021-10-01" @default.
• W3213901742 modified "2023-09-26" @default.
• W3213901742 title "P-060: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single cell transcriptomics" @default.
• W3213901742 doi "https://doi.org/10.1016/s2152-2650(21)02194-7" @default.
• W3213901742 hasPublicationYear "2021" @default.
• W3213901742 type Work @default.
• W3213901742 sameAs 3213901742 @default.
• W3213901742 citedByCount "0" @default.
• W3213901742 crossrefType "journal-article" @default.
• W3213901742 hasAuthorship W3213901742A5001651530 @default.
• W3213901742 hasAuthorship W3213901742A5006013275 @default.
• W3213901742 hasAuthorship W3213901742A5007067641 @default.
• W3213901742 hasAuthorship W3213901742A5019570679 @default.
• W3213901742 hasAuthorship W3213901742A5023929019 @default.
• W3213901742 hasAuthorship W3213901742A5028388949 @default.
• W3213901742 hasAuthorship W3213901742A5029489836 @default.
• W3213901742 hasAuthorship W3213901742A5034285292 @default.
• W3213901742 hasAuthorship W3213901742A5038346337 @default.
• W3213901742 hasAuthorship W3213901742A5052636654 @default.
• W3213901742 hasAuthorship W3213901742A5055916434 @default.
• W3213901742 hasAuthorship W3213901742A5061170036 @default.
• W3213901742 hasAuthorship W3213901742A5061326208 @default.
• W3213901742 hasAuthorship W3213901742A5061648636 @default.
• W3213901742 hasAuthorship W3213901742A5063410783 @default.
• W3213901742 hasAuthorship W3213901742A5066282715 @default.
• W3213901742 hasAuthorship W3213901742A5070221339 @default.
• W3213901742 hasAuthorship W3213901742A5081998180 @default.
• W3213901742 hasAuthorship W3213901742A5084645599 @default.
• W3213901742 hasAuthorship W3213901742A5091002491 @default.
• W3213901742 hasConcept C104317684 @default.
• W3213901742 hasConcept C127561419 @default.
• W3213901742 hasConcept C1491633281 @default.
• W3213901742 hasConcept C150194340 @default.
• W3213901742 hasConcept C153911025 @default.
• W3213901742 hasConcept C162317418 @default.
• W3213901742 hasConcept C203014093 @default.
• W3213901742 hasConcept C2776364478 @default.
• W3213901742 hasConcept C2780007613 @default.
• W3213901742 hasConcept C502942594 @default.
• W3213901742 hasConcept C54355233 @default.
• W3213901742 hasConcept C553184892 @default.
• W3213901742 hasConcept C86803240 @default.
• W3213901742 hasConcept C8891405 @default.
• W3213901742 hasConceptScore W3213901742C104317684 @default.
• W3213901742 hasConceptScore W3213901742C127561419 @default.
• W3213901742 hasConceptScore W3213901742C1491633281 @default.
• W3213901742 hasConceptScore W3213901742C150194340 @default.
• W3213901742 hasConceptScore W3213901742C153911025 @default.
• W3213901742 hasConceptScore W3213901742C162317418 @default.
• W3213901742 hasConceptScore W3213901742C203014093 @default.
• W3213901742 hasConceptScore W3213901742C2776364478 @default.
• W3213901742 hasConceptScore W3213901742C2780007613 @default.
• W3213901742 hasConceptScore W3213901742C502942594 @default.
• W3213901742 hasConceptScore W3213901742C54355233 @default.
• W3213901742 hasConceptScore W3213901742C553184892 @default.
• W3213901742 hasConceptScore W3213901742C86803240 @default.
• W3213901742 hasConceptScore W3213901742C8891405 @default.
• W3213901742 hasLocation W32139017421 @default.
• W3213901742 hasOpenAccess W3213901742 @default.
• W3213901742 hasPrimaryLocation W32139017421 @default.
• W3213901742 hasRelatedWork W170226654 @default.
• W3213901742 hasRelatedWork W1995478390 @default.
• W3213901742 hasRelatedWork W2009966535 @default.
• W3213901742 hasRelatedWork W2086982783 @default.
• W3213901742 hasRelatedWork W2102579905 @default.
• W3213901742 hasRelatedWork W2165862110 @default.
• W3213901742 hasRelatedWork W2734403094 @default.
• W3213901742 hasRelatedWork W3012091774 @default.
• W3213901742 hasRelatedWork W3201422854 @default.
• W3213901742 hasRelatedWork W4247273247 @default.
• W3213901742 hasVolume "21" @default.
• W3213901742 isParatext "false" @default.
• W3213901742 isRetracted "false" @default.
• W3213901742 magId "3213901742" @default.
• W3213901742 workType "article" @default.